Evaluation of Safety and Efficacy of DM-28 for Treatment of Moderate to Severe Ocular Dryness

PMCF Study to Evaluate Performance and Safety of "Hyaluronic Acid (HA)-Based Eyedrops" Used to Relieve Dry Eye Symptoms

NCT05807360 ·Status: COMPLETED ·Phase: NA

Evaluating the Efficacy and Safety of TJO-087 in Moderate to Severe Dry Eye Disease Patients

NCT05245604 ·Status: UNKNOWN ·Phase: PHASE3

Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease

NCT02831387 ·Status: TERMINATED ·Phase: PHASE2

Study of DE-089 Ophthalmic Solution in Patients With Dry Eye

NCT01101984 ·Status: COMPLETED ·Phase: NA

PMCF Study to Evaluate Performance and Safety of "HPMC-based Eyedrops" Used to Relieve Dry Eye Symptoms

NCT05825599 ·Status: COMPLETED ·Phase: NA

Comparing the Quality of Topical Autologous Serum in Different Etiologies of Dry Eye Syndrome

NCT02774707 ·Status: UNKNOWN

Study of the Effect of Diquafosol Tetrasodium Ophthalmic Solution, 2% Versus Placebo in Dry Eye Subjects (P08634)

NCT00600288 ·Status: COMPLETED ·Phase: PHASE3

A Study Evaluating the Efficacy and Safety of RCI001 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye

NCT07068958 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Efficacy Comparison of Two Kinds of Treatment in Treating Dry Eye Caused by Meibomian Gland Dysfunction

NCT02958514 ·Status: COMPLETED ·Phase: NA

Evaluating HA 0.15% Compared With Cyclosporine 0.05%, and Efficacy of Combination Therapy in Dry Eye Disease Patients

NCT04127851 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of BUFY02 Versus TRB02 in the Treatment of Dry Eye Disease

NCT05865457 ·Status: RECRUITING ·Phase: NA

A Randomized, Double Masked, Clinical Study of Subjects With Dry Eye Syndrome

NCT03162783 ·Status: COMPLETED ·Phase: PHASE2

Assessing Safety and Efficacy of DE-089 Ophthalmic Solution in Patients With Dry Eye Disease

NCT03216096 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety, Tolerability, and Efficacy of A197 in Subjects With Dry Eye Disease

NCT05238597 ·Status: COMPLETED ·Phase: PHASE2

Phase III Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry Eye

NCT01240382 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Two Artificial Tears in Dry Eye Subjects

NCT01010282 ·Status: COMPLETED ·Phase: NA

YM-101 Eye Drops in the Treatment of Dry Eye Syndrome

NCT06792903 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease

NCT01239069 ·Status: COMPLETED ·Phase: PHASE2

Study on Safety and Performance of an Artificial Tear in Dry Eye Treatment in Subjects With Ocular Surface Inflammation

NCT04633863 ·Status: COMPLETED ·Phase: NA

Efficacy and Safety of BUFY01 Versus SVS20 in the Treatment of Dry Eye Disease

NCT05865379 ·Status: RECRUITING ·Phase: NA

Dose-response Study of OPC-12759 Ophthalmic Suspension

NCT00234078 ·Status: COMPLETED ·Phase: PHASE2

PMCF Study to Evaluate Performance and Safety of "Ocular Drops Based Upon Carmellose" Used to Relieve Dry Eye Symptoms

NCT05825352 ·Status: COMPLETED ·Phase: NA

Phase II Study of DA-6034 Eye Drops in Dry Eye Syndrome

NCT01670357 ·Status: COMPLETED ·Phase: PHASE2

PMCF Study to Evaluate Performance and Safety of "CLHA-based Eyedrops" Used to Improve Lacrimal Abnormalities

NCT05823961 ·Status: COMPLETED ·Phase: NA

Efficacy of 0.28% Sodium Hyaluronate Eye Drops in Patient with Moderate to Severe Dry Eye

NCT06860659 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4